Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2005-9-15
pubmed:abstractText
Ghrelin is a novel growth hormone (GH)-releasing peptide that also induces a positive energy balance by decreasing fat utility and stimulating feeding through GH-independent mechanisms. We investigated whether ghrelin improves cachexia and functional capacity in patients with COPD.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0012-3692
pubmed:author
pubmed:issnType
Print
pubmed:volume
128
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1187-93
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:16162705-Aged, pubmed-meshheading:16162705-Aged, 80 and over, pubmed-meshheading:16162705-Body Composition, pubmed-meshheading:16162705-Cachexia, pubmed-meshheading:16162705-Exercise Tolerance, pubmed-meshheading:16162705-Female, pubmed-meshheading:16162705-Ghrelin, pubmed-meshheading:16162705-Growth Hormone-Releasing Hormone, pubmed-meshheading:16162705-Humans, pubmed-meshheading:16162705-Male, pubmed-meshheading:16162705-Muscle Weakness, pubmed-meshheading:16162705-Muscular Atrophy, pubmed-meshheading:16162705-Peptide Hormones, pubmed-meshheading:16162705-Pilot Projects, pubmed-meshheading:16162705-Pulmonary Disease, Chronic Obstructive, pubmed-meshheading:16162705-Recovery of Function, pubmed-meshheading:16162705-Respiratory Function Tests, pubmed-meshheading:16162705-Respiratory System, pubmed-meshheading:16162705-Sympathetic Nervous System
pubmed:year
2005
pubmed:articleTitle
Treatment of cachexia with ghrelin in patients with COPD.
pubmed:affiliation
Department of Internal Medicine, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan. nnagaya@ri.ncvc.go.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't